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ABSTRACT
Antibodies are proteins of the immune system that exhibit exquisite specificity to their binding 
partners, called antigens. Binding occurs at the hypervariable region (Fv), which is capable of 
discriminating even enantiomeric molecules. By targeting on the DNA sequences that code for Fv 
and expressing it as a protein, the binding properties of an antibody can be assessed. In this 
project, the heavy and light chains of the Fv region (Vh and V[_) of an anti-amino acid antibody 
(anti-phenylalanine 67.36) were linked using a short nucleotide linker and four primers designed 
from previously determined sequences of Vh and V|_. The resulting V|-H¡nker-V|_(HIL) construct - a 
single chain variable fragment (67.36 HIL scFv) - was inserted into a TOPO cloning vector and 
transformed into E. coli BL 21 expression cells. 1 L cultures were grown at 37°, 30° and 27 °C. 
Cells were collected, resuspended and lysed to release the protein of interest. Isolation and 
purification was performed using a metal (cobalt) affinity chromatography resin. Characterization by 
SDS-PAGE indicated a correlation between incubation temperature and extent of expression. 
Noncompetitive ELISA tests revealed a functional 67.36 HIL scFv. However, further tests e.g., 
competitive ELISA, must be carried out to confirm an enantiomeric preference.
INTRODUCTION
I. Chirality
substituents. Such molecules have essentially the same physical properties, but may show 
different behavior in a chiral environment (e.g., the human body). Most biological molecules are 
chiral and all organisms on Earth and their numerous physiological processes are stereoselective, 
utilizing, e.g., amino acids and sugars in only one of the two possible mirror-image forms. Important 
biological macromolecules that are stereoselective are enzymes, receptors, and antibodies.
Chirality is the structural characteristic that makes it 
impossible to superimpose a molecule with its mirror image. 
The most common form of chirality occurs in molecules that 
possess an asymmetric center. The two mirror images, called
enantiomers, are identical in atomic constitution and bonding, 
but differ in the three-dimensional arrangement of its
II. The Antibody
Antibodies are proteins produced by B-cells to combat the numerous foreign invaders our 
immune system encounters on a daily basis. The basic four-chain structure of antibodies is shown 
in figure 1. Generally Y-shaped, it is comprised of two identical light and heavy chains. Antigen 
recognition and interaction occurs in the antigen-binding site located at the ends of the “arms” of 
the molecule.
There are generally five different classes of antibodies in existence: IgA, IgD, IgE, IgG, and
IgM. The general four-chain structure is common for all 
monomeric immunoglobulin molecules. Polymeric 
immunoglobulins of higher molecular weights are formed by 
2-6 four-chain subunits. Therefore they differ not only in their 
physiological roles but also in their overall structures. For 
example, IgA is a dimer comprised of two Y-shaped antibody 
subunits. In this research project, 67.36, a type of IgG 
antibody, was studied and observed.
Figure 1. General Structure of Antibodies
II. A Closer Look - Structural Basis for Specificity
Form a structural point of view (figure 2), IgG antibodies are a particular class of 
immunoglobulins that have been extensively studied because of the dominant role they play in a 
mature immune response.
The IgG molecule can be broken down into two 
regions: Fc and Fab. Each immunoglobulin light (L) 
or heavy (H) chain is structurally segmented into 
domains that are either of the variable type (Vl and 
Vh) or the constant type (CHi, CH2, or CH3). The 
Fab region contains the antigen-binding site, which 
is comprised of the hypervariable Fv region (Vl + 
Vh). It is important to note that this area of highly 
variable amino acids are confined to 6 protein loops
Figure 2. IgG Structure
that cluster together at the end of the Fab fragments to form a continuous hypervariable surface. It 
is this region that is responsible for antibody specificity and is the area of focus for this research 
project.
The specificity of antibodies is incredible, able to differentiate between enantiomers. As 
mentioned earlier, enantiomers are molecules that are optical isomers, or mirror images, of one 
another. These non-superimposable molecules can be distinguished by the direction in which they 
rotate the plane of polarization of polarized light and are referred to, therefore, as being 
dextrorotatory (D-type or right handed) or laevorotatory (L-type or left handed).
Since antibodies can be raised against virtually any compound, practical applications of 
antibody stereoselectivity is currently being researched; this can range from the detection of 
enantiomeric impurity in drugs to the chromatographic separation of enantiomeric mixtures.
III. Importance and Goals of this Project
All organisms on Earth use amino acids and sugars in only one of the two possible mirror- 
image forms. Since enantiomers are essentially the same molecule, possessing the same 
molecular weight and physical properties, separating the two forms is not only difficult but also 
time-consuming. This makes it challenging to separate racemic samples, which contain both forms. 
This is especially relevant in drugs manufactured for human consumption because minor 
enantiomeric impurities may cause sever pharmacologic and toxicologic side effects. Thus 
antibody practical applications for antibody stereoselectivity can range from the detection of 
enantiomeric impurity in drugs to the chromatographic separation of enantiomeric mixtures 
Because of the effectiveness of antibody stereoselectivity, applications are being 
developed to attain analytical techniques for the precise determination of 
biorelevant chrial molecules. Currently there are several analytical 
techniques used for separating
My research project focuses on the production of a scFv 
fragment from the antigen-binding site (Fab) of anti-AA 67.36, an 
antibody to phenylalanine, and the investigation of its binding properties







In order to perform the experiments and tests necessary to investigate antibody specificity, 
one needs a constant source of a single type of antibody that are all built alike and manufactured 
by a single clone of plasma cells, or monoclonal antibodies. Possible sources for monoclonal 
antibodies are spleen cells. Since they are responsible for B-cell production, spleen cells contain 
the genetic information that give rise to antibody production. B-cells are significant because each 
carry a different membrane-bound antibody molecule on its surface. Therefore if an antigen is 
introduced and binds to a particular B-cell, it stimulates this cell to divide. The result is the secretion 
of large amounts of the same antibody in soluble form.
However, there are drawbacks if one intends to harvest monoclonal antibodies through this 
procedure. First of all, the response of the immune system to any antigen, even the simplest, is 
polyclonal. That is, the system manufactures antibodies of a great range of structures both in their 
binding regions as well as in their effector regions. In addition, even if the isolation of a single 
antibody-secreting cell were successful and the cell is placed in culture, it would die out after a few 
generations because of the limited growth potential of ail normal somatic cells.
The solution to this problem is Hybridoma Technology where single antibody forming cells 
are fused to tumor cells grown in culture, producing hybridoma cells. In this process, antibodies are 
‘"raised” by injecting an animal (usually mice or rabbits) with an antigen, X for example. Repeated 
injections of the same antigen at intervals of several weeks stimulates specific B-cells to secrete 
large amounts of anti-X antibodies in the bloodstream. The cells that produce these antibodies are 
fused with tumor cells and grown in a selective medium, HAT (hypoxanthine/aminoptherin/ 
thymine), which only allows hybridoma cells to grow. The supernatant was extracted from 
microcultures and screened for secretion of the desired antibody. Lastly, the cells with positive 
results were subculture by limiting dilution such that each culture contains hybridomas with single 
antibody specificity. Since there is an excess of these anti-X antibody-producing cells, the 
likelihood of attaining the antibodies of interest is much greater. The result are cells monoclonal 
antibodies can be raised by fusing single antibody forming cells to tumor cells grown in culture. The 
resulting cell is called hybridoma.
II. Degenerate Primers
Once the specific hybridoma cell has been attained, it is now possible to gain access to the 
genes of the cell that code for the antibody molecule. Within the cell is the mRNA for both light 
chain and heavy chain production. The next step is now to purify the mRNA using QuickPrep 
mRNA purification kit. Once the mRNA has been isolated, we can have the cDNA for the chains 
since mRNA is not very stable and cDNA is. To focus on these hypervariable regions, degenerate 
primers were used. Degenerate primers are a library of primers that allow wobbles at specific 
locations.




GTT CCg B M gAG GTG CAG CTG GAG GAG TCT GGG GGA GGC H A  GTG AAG CCT GGA 
GGG TCC CTG AAA CTC TCC TGC GCA GCC TCT GGA TTC ACT TTC AGT AAC TAT GAC ATG TCT 
TGG GTT CGC CAG ACT CCA GAG AAG AGA CTG GAG TGG GTC ACA TCT ATT AGT AGT GGT GGT 
TAC ACC TAC TAT CCA GAC AGT GTG AAG GGC CGA TTC ACC ATC TCC AGA GAT AAT GTC AGG 
AAC ATC CTG TAC CTG CAA ATG AGC AGT CTG AGG TCT GAA GAC ACG GCC ATG TAT TAC TGT 
GCA AGA GCC CTT TAT GAC TAC ACT ACT AGC CCC TGG TTT GCT TAC TGG GGC CAA GGG ACT 
CTG GTC ACT GTC TCT GCA GCC AAA ACG ACA CCC CCA TCT GTC TAT TCC
Light
Chain
TGG GAT A n  GTG CTG ACC CAA ACT ACA GCA ATC ATG TCT GCA TCT CCA TGG GAA 
AAG GTC ACC ATG ACC TGC AGG GCC AGC TCA AGT GTA AGT TCC AGT TAC TTG CAC TGG TAC 
CAG CAG AAG TCA GGT GCC TCC CCC AAA CTC TGG A n  TAT AGC ACA TCC AAC TTG GCC TCT 
GGA GTC CCT GCT CGC TTC AGT GGC AGT GGG TCT GGG ACC TCT TAC TCT CTC ACA ATC AGC 
AGT GTG GAG GCT GAA GAT GCC GCC ACT TAT TAC TGC CAG CAG TAC AGT GGT ACC CCG CTC 
ACG H C  GGT GCT GGG ACC AAG CTG GAG CTG AAG CGG GCT GAT GCT GCA CCA ACT GTA TCA 
GGC
Methods
I. Amplifying Vh and Vl via PCR
Polymerase chain reaction (PCR) is a common method of creating copies of specific 
fragments of DNA. PCR rapidly amplifies a single DNA molecule into many billions of molecules. It 
creates copies by mimicking how DNA is replicated in a cell, however using temperature as a 
means of manipulating the structure of the double stranded DNA (dsDNA):





# of Cycles Purpose
Initial denaturation 94 1 1 Separates dsDNA into two template 
strands
Denaturation 94 1 Same as above
Annealing 55 1 35 Anneals primers to template
Elongation 72 2 Polymerase elongates primers to 
create new strands from template
Final Elongation 72 10 1 Finish elongation 
Reform dsDNA
To amplify Vh and Vl ,the following solutions were added into a small Eppendorf PCR tube:
Vh Vl
Buffer 2 uL 2 uL
MgCI2 2 2
‘Primers *67.36 HIL HR 0.4 *67.36 HILLR 0.4
*67.36 HILHF 0.4 *67.36 HIL LF 0.4
dNTP 0.4 0.4
Sterile H20 13.9 13.9
‘Template *1’stock 0.4 *4’stock 0.4
Tag polymerase______________ 02_______________________ 0.2
TOTAL VOLUME 20 ul 20 ul
After mixing well, a drop of mineral oil was added to the top of the solution to prevent 
evaporation during denaturation. The samples were placed in the PCR machine and allowed to run 
for 35 cycles according to the specifications on temperature and time as shown in table 1 (program 
#9 in PCR). At the end of the program, the tubes were placed in -70° C freezer and the mineral oil 
drop was removed from the surface; since mineral oil does not solidify, freezing is an efficient way 
to remove the mineral oil from the surface without disturbing or removing any of the precious DNA 
sample that remains in solid-form. Then, agarose-gel electrophoresis was utilized to assure that 
amplfication was carried out and to check final molecular weight of fragments.
Electrophoresis is a way of separating out charged particles. When a sample is placed in a 
semi-solid matrix or gel and exposed to an electric field, the ions or molecules migrate through the
gel in response to the field. Smaller particles travel faster and move further than larger ones. Highly 
charged particles are also more responsive to the electric field.
The sugar phosphate backbone of DNA has a negative charge in neutral to basic solution. 
Therefore when an electric charge is placed through the sample, it will move from the negative 
(cathode) pole to the positive (anode) pole. A buffer solution In the unit stops the solution from 
becoming acidic. The DNA sample was placed in a gelatinous matrix, agarose (1.2% agarose: 1.2 
g/60 mL TAE buffer) and exposed to an electric field. Along with the sample, loading dye was 
added to increase the density of the solution causing it to sink to the bottom of the agarose gel. In 
addition, the dyes contain bromophenol blue and xylene cyanol, both negatively charged dyes that 
will migrate to the positive pole as well.
Since DNA is not visible in the gel, the dyes give an indication of how fart he nucleic acids 
have migrated. Once the samples have migrated to the bottom of the gel, the electric current was 
stopped. The separated bands were visualized by staining the gels with ethidium bromide, which 
become fluorescent under ultraviolet light. A photograph of the gel was taken as shown below 
displays two distinct bands. These bands correspond with the known molecular weights of Vh and 
VL:
• Heavy Chain - 408 bp
400 b|
II. Designing the Linker
The linker sequence is a short nucleotide chain that must connect the Vh and Vl domains 
of a given Fv without perturbing contacts or interfering with domain folding. Various factors are 
taken into consideration to optimize the chances of obtaining a functional fragment. The overall 
length and %GC holds great significance since both directly affects the melting temperature (Tm). 
The melting temperature is the temperature in which double stranded DNA can be separated into 
single strands. Since the linker will be directly attached to the heavy and light chains, its melting 
temperature must be relatively close to the Tm of the scFV.
Light chain - 370 bp
The longer the length of the sequence, the more energy required to separate the strands, 
thus an increased Tm. Increased %GC or percent guanine-cytosine has a similar effect. Base- 
pairing nucleotides make up the ladder of double helix DNA. Guanine-cytosine base pairs are 
stabilized by 3 hydrogen bonds, compared to 2 hydrogen bonds between adenine-thymine. The 
more stabilized G-C pairing requires more energy to separate thus increasing Tm as more GC are 
placed.
For the linker in creating 67.36 scFV, the linker must remain flexible, thus Gly and Ser 
residues were introduced. Solubility is also important since the resulting protein samples must be 
kept in solution during use and long-term storage. To enhance solubility, Lys and Glu were 
incorporated. Degradation from proteases is imminent for proteins that are not in its native 
environment. To prevent protease susceptibility, Pro residues were included. Lastly, the linker 
sequence must be in an optimal length to reduce multi-dimer formation.
Sequence Length
Linker
5’ AAC TTT AGT GCT ADD TTC ACC 
ACT CCC GGG TTT GCC GCT ACC 
GGA AGT AGA GCC 3’
54 bp
III. Designing the Primers
The steps in creating primers is similar to creating the linker, considering the length and %GC 
to remain in a safe range. However with the primers, previously determined sequences of the 
heavy and light chain were used to determine the exact amino acid composition. In addition:
• Primers were created to incorporate the linker sequence
• Proper length: approx 21 -24 bases
• Proper alignment with sequences; must occur in 5’ —► 3’ direction.
• Proper melting temp Tm = 60-65 C (annealing temp = 55 C)
% GC = below 50% ideal
acceptable if 50-55%
VH linker VL






1. Heavy Forward 5’ GTT CCG GAA TTC GAG GTG CAG3’ 21 59.4 57.1%
2. Heavy Reverse 5’ GGA AGA TCT ATA GAC AGA TGG GGGTGT3’ 27 60.8 48.1%
3. Light Forward 5’ TGG GAG CTC GAT ATT GTG CTG ACC 3’ 24 62.3 54.2%
4. Light Reverse 5’ GCC CTT AAG TGA TAC AGT TGG TGC 3’ 24 59.5 45.8%
IV. Creating scFV
Using polymerase chain reaction (PCR), the primers were elongated to form scFv HIL. 
Since the length of the linker, Vh and V l were known (54, 370 and 408 bp, respectively), the 
molecular weight of 67.36 scFv HIL could be calculated. The primers are strategically placed, 
accompanied by portions of the linkers sequence in order for elongation to occur in the 5’ -> 3’ 
direction (see figure 5). This resulted in a single chain fragment.
To begin ligation, the following solutions were added to an eppendorf tube:
VH —  VL
Electrophoretic separation in an agarose gel revealed a band at about 800 bp, which 
corresponds to 67.36 scFv HIL. The band was then isolated from the gel via Qiagen® Gel 
Extraction Kit. This kit is designed to extract and purify DNA fragments from standard or low-melt 
agarose gels in TAE or TBE buffer.
• The DNA fragment was excised from the agarose gel with a clean, sharp scalpel.
• The gel slice was weighed in a colorless tube. 3 volumes of Buffer QG was added 
to 1 volume of gel.
• To dissolve the gel, it was incubated at 50 C for 10 min. After the gel slice has 
been dissolved completely, the color of the mixture was checked to assure it 
remained yellow. This indicates it is in the optimal pH.
• 1 gel volume of isopropanol was added to the sample and mixed thoroughly
• A QIAquick spin column is placed into a 2 mL collection tube.
• The sample was applied onto the QIAquick column to bind the DNA. The tube was 
centrifuged for 1 min
• The flow-through was discarded and 0.5 mL of Buffer QG was added to the 
column and centrifuged for 1 min. This step removed all traced of agarose
• The column was then washed by adding 0.75 mL of Buffer PE and centrifuged for 
1 min. The flow through was discarded and the tube was centrifuged for an 
additional 1 min
• The QIAquick column was placed into a clean, 1.5 mL Eppendorf tube.
• The DNA was eluted by adding 50 uL of H20 at the center of the column. The 
tube was centrifuged at high speed for 1 min.
IV. Inserting scFV into TOPO Cloning Vector
At this point in the experiment, 67.36 is nothing more than a short fragment of DNA. In 
order for 67.36 HIL to be expressed as a protein, it must first be inserted into a cloning vector. A 
cloning vector is a plasmid DNA that allows the introduction of foreign DNA fragments. In this 
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TOPO TA Cloning provides a highly efficient, 5-minute, one-step cloning strategy for the 
direct insertion of Taq polymerase-amplified PCR products into a plasmid vector. Taq polymerase
has a nontemplate-dependent terminal transferase activity that adds a single deoxyadenosine (A)
to the 3’ ends of PCR products. The linearized vector has a single, overhanging 3’ deoxythymidine
(T) residues. This allows PCR insert to ligate efficiently with 
the vector.
67.36 scFV HIL was directly inserted into a TOPO 
cloning vector and transformed into TOP 10 cloning cells. 
First, 400 ng of the DNA fragment was added with 1 uL Dilute 
Salt Solution and 1 uL TOPO vector. Water was added to 
bring up the total volume to 6 uL. The solution was incubated 
for 5 minutes at room temperature. Then it was transformed 
into TOP 10 cells using electroporation. 250 uL of SOC medium was added and the solution was
allowed to incubate for 1 hr at 37 °C in order for cells to recover. 250 uL of the solution was plated
on agar medium and incubated overnight at 37 °C. Each resulting colony was analyzed by PCR in 
order to determine if the insertion was successful. The agarose gel photograph displays colonies 
that contained the insert. Only plasmids of positive colonies were isolated and transformed into £ 
























TOTAL VOLUME 20 uL per colony
VI. Expression of Protein
Once positive colonies were identified, a DNA purification kit (Promega Wizard® Plus 
Midipreps) was used to remove and isolate plasmids with the 67.36 HIL scFv insertions from cells. 
Plasmids were then transformed into ampicillin resistant £  coli BL 21 expression cells by 
electroporation. Transformed expression cells were placed in TB broth containing 1mL/mL
ampicillin, 0.17 M KH2PO4, and 0.72 M K2HPO4.1L cultures were incubated at 37°, 30° and 27° 
C. After a 24-hour incubation period, cells were induced with IPTG. 1.5 hours after induction, cells 
were collected by centrifugation at 5,000 x g. The supernatant was discarded and the cell pellet 
was frozen overnight at -20° C.
VII. Isolation and Purification of protein
Prior to cell lysis, cells were thawed on ice. 3 mL of extraction/wash buffer (50 mM 
NaH2P04, 300 mM NaCI) per 1 g of cells were added to resuspend the pellet. DNAse was then 
added (100 - 300 mL) to decrease the viscosity of the solution and allow more efficient cell lysis. 
Cells were lysed in a French Press at 2000 psi. The resulting solution was collected and 
centrifuged at 18,000 x g. The supernatant, containing the protein of interest, was saved while the 
cell pellet was discarded. The protein of interest contained a histidine(His)-tag, which was captured 
on a metal affinity chromatography resin. The TALON® cobalt resin contains sites with a high 
affinity for His-tags and, therefore, allows purification of the protein from impurities. After 
consecutive washings, the protein was eluted with elution buffer (50 mM Na2HP04,300 mM NaCI, 
150 mM Imidazole). 1 mL fractions were collected.
SDS-polyacrylamide gel electrophoresis was used to characterize the first five elution 
fractions as well as the supernatant, pellet, and flow-throughs obtained in the washing steps. 
Results demonstrate that much of the protein was retained on the cobalt column even after 
repeated washings. The protein was not found in the supernatant, pellet, or flow-throughs. At lower 
incubation temperatures, the extent of expression was more pronounced.
Elution Fractions 37 °C Elution Fractions 27 °C
VIII. Determining Functionality
Antibody binding was monitored in a noncompetitive enzyme-linked immunosorbent assay 
(ELISA) using bovine serum albumin (BSA), p-azo-D-Phe-BSA, and p-azo-L-Phe-BSA as solid 
phase coatings (100 mL/well; 1 mg/mL in 50 mM carbonate buffer, pH 9.6; 14 h at 4 °C). 
Unoccupied adsorption sites were blocked with 1% gelatin in PBS/Tween (250 mL/well; 2 h at 37 
°C). Fraction #3 (of 27 and 30 °C incubations) was diluted as follows: 1:1, 1:2, 1:5, 1:10, 1:20, 
1:40. 50 mL- samples were added to each well and incubated for 2 h at 37 °C. Bound antibody 
was detected with anti-His- or anti-mouse-horseradish peroxidase-conjugated antibodies. (1:5,000
plotted against the concentration (see graphs in end pages).
ELISA RESULTS & DISCUSSION
Result noncompetitive ELISA results show that cells grown at 27 °C and 30 °C expressed 
a functional 67.36 HIL scFv. At 27 °C, the protein binds to both p-azo-D-Phe-BSA and p-azo-L- 
Phe-BSA, with a slight preference to the latter. At 30 °C  a more pronounced preference is 
observed. While these results suggest that the antibody 67.36 HIL scFv is stereoselective, it is 
imperative that further tests, e.g., competitive ELISAs, are carried out to verify its enantiomeric 
preference. A competitive ELISA, in which antibodies are allowed to bind to free antigen in solution, 
is much more suited to unambiguously determine antibody specificity and stereoselectivity
In conclusion, we successfully ligated the light and heavy variable regions to create 67.36 
HIL scFv. We were able to express 67.36 HIL scFV as a protein and found a temperature 
dependence on the extent of expression. We determined that the expressed protein was functional. 
Noncompetitive ELISA tests revealed that cells grown at 30 °C expressed protein with a 
preference towards p-azo-L-Phe-BSA. In the future, competitive ELISA tests will be performed to 
confirm the observed enantiomeric preference
Antibody binding to the immobilized antigen 
was determined through a visible color change 
resulting from the enzymatic conversion of o- 
phenylendiamine (100 mL/well).
Using a spectrophotometer, the absorbance 












67.36 HIL Binding Curve 27 °C












67.36 HIL Binding Curve 27 °C 
BSA values subtracted












67.36 HIL Binding Curve 30 °C












67.36 HIL Binding Curve 30 °C 
BSA values subtracted
Dilution of fraction #3
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